These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5367516)

  • 1. Serum levels and urinary excretion of chloramphenicol in the presence of isoniazid and salicylate.
    Mattila MJ; Takki S; Heino AE
    Ann Med Exp Biol Fenn; 1969; 47(3):203-8. PubMed ID: 5367516
    [No Abstract]   [Full Text] [Related]  

  • 2. Chloromycetin palmitate; observations on absorption, blood serum levels, and urinary excretion.
    YOW EM; TAYLOR FM; HIRSCH J; FRANKEL RA; CARNES HE
    J Pediatr; 1953 Feb; 42(2):151-6. PubMed ID: 13023513
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum levels, urinary excretion, and side-effects of cycloserine in the presence of isoniazid and p-aminosalicylic acid.
    Mattila MJ; Nieminen E; Tiitinen H
    Scand J Respir Dis; 1969; 50(4):291-300. PubMed ID: 5380786
    [No Abstract]   [Full Text] [Related]  

  • 4. Absorption and excretion of two chloramphenicol products in humans after oral administration.
    Bartelloni PJ; Calia FM; Minchew BH; Beisel WR; Ley HL
    Am J Med Sci; 1969 Sep; 258(3):203-8. PubMed ID: 5824862
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects.
    Glazko AJ; Kinkel AW; Alegnani WC; Holmes EL
    Clin Pharmacol Ther; 1968; 9(4):472-83. PubMed ID: 5655479
    [No Abstract]   [Full Text] [Related]  

  • 6. Concentration of chloramphenicol in the urine and blood in relation to renal function.
    Lindberg AA; Nilsson LH; Bucht H; Kallings LO
    Br Med J; 1966 Sep; 2(5516):724-8. PubMed ID: 5917389
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of chloramphenicol on the mother and baby. II. Transfer, absorption, excretion and adverse effects of chloramphenicol in the newborn infant].
    Kunii K
    Jpn J Antibiot; 1970 Aug; 23(4):363-78. PubMed ID: 5312787
    [No Abstract]   [Full Text] [Related]  

  • 8. Special characteristics of absorption and excretion of chloramphenicol in premature and newborn infants.
    Nishimura T; Kotani Y
    Bull Osaka Med Sch; 1970 Oct; 16(2):169-81. PubMed ID: 5511545
    [No Abstract]   [Full Text] [Related]  

  • 9. [Specificity of absorption and excretion of chloramphenicol in premature and newborn infants].
    Ura S
    Nihon Shonika Gakkai Zasshi; 1968 May; 72(5):697-705. PubMed ID: 5748795
    [No Abstract]   [Full Text] [Related]  

  • 10. Excretion of chloramphenicol and its metabolites by the chronically diseased kidney (with respect to the theory of adaptive nephrons).
    Schück O; Prát V; Grafnetterová J; Kotanová E; Reitschlägerová V; David I
    Int J Clin Pharmacol; 1974 Jul; 10(1):33-43. PubMed ID: 4851956
    [No Abstract]   [Full Text] [Related]  

  • 11. Chloramphenicol succinate kinetics in infants and young children.
    Sack CM; Koup JR; Opheim KE; Neeley N; Smith AL
    Pediatr Pharmacol (New York); 1982; 2(2):93-103. PubMed ID: 12760401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the biological availability of chloramphenicol.
    Koeleman HA; Van Oudtshoorn MC
    S Afr Med J; 1973 Jan; 47(3):94-9. PubMed ID: 4631423
    [No Abstract]   [Full Text] [Related]  

  • 13. [Kinetics of the absorption of D-chloramphenicol following its peroral and intramuscular administration].
    Nadvornikova G; Grafnetterova I; Shiuk O
    Antibiotiki; 1974 Dec; 19(12):1068-73. PubMed ID: 4447345
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance effect to the para-amino-salicylic acid and the isoniazid phenyl-para-amino-salicylate].
    Torning K
    Prensa Med Argent; 1966; 53(9):1055-9. PubMed ID: 6004190
    [No Abstract]   [Full Text] [Related]  

  • 15. [The influence of pharmaceutical and physico-chemical factors of drugs on the result of clinical trials: chloramphenicol palmitate].
    van Oudtshoorn MC; Potgieter FJ; Koeleman HA; Pantonowitz LD
    S Afr Med J; 1969 Nov; 43(45):1375-6. PubMed ID: 4902056
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ambulatory prescription of chloramphenicol].
    Schneider I; Walther H
    Z Arztl Fortbild (Jena); 1970 Jun; 64(11):550-6. PubMed ID: 5520098
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative studies of chloramphenicol activity, fate and absorption in different suspensions.
    Galal EE; Raggal MH; Kamel HH; Sabbagh H; Mahmoud MA; Azzam AB
    J Egypt Med Assoc; 1965; 48():Suppl:89-97. PubMed ID: 5873680
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on absorption kinetics of different brands of chloramphenicol.
    Lakshamana M; Seth SD; Shriniwas E; Arora RB
    Indian J Med Res; 1973 Jan; 61(1):138-44. PubMed ID: 4585703
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of chloramphenicol on serum salicylate concentrations in cats and dogs.
    Akesson CE; Linero PE
    Am J Vet Res; 1982 Aug; 43(8):1471-2. PubMed ID: 7103230
    [No Abstract]   [Full Text] [Related]  

  • 20. Salicylates and iron absorption. Competition of salicylate and gastric juice for iron.
    Davis PS; Deller DJ
    Gastroenterology; 1967 Apr; 52(4):691-4. PubMed ID: 6021792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.